Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01620086 · ClinicalTrials.gov registry record · NA
Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01620086: Completed NA study, sponsored by University of Arkansas.
NCT01620086 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01620086, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study compares the efficacy of low and high frequency repetitive transcranial magnetic stimulation (rTMS) as a means of treating subjects with schizophrenia. Magnetic pulses delivered over the scalp cause brain activity. This activity has been shown to help decrease the intensity and frequency of auditory hallucinations (AH) in schizophrenia. The investigators will compare whether low or high frequencies work best. The investigators will also examine what changes occur in the brain that are related to improvement.
Primary Outcome
The Auditory Hallucinations Questionnaire (AHQ) will be used to determine the patient's perceptions of change in auditory hallucinations(s). Normal controls do not fill out this measure because they do not have auditory hallucinations. Change in the average results of this test between the baseline and active treatment weeks (1 and 10 Hz) will be measured. The range of scores is 0-70, higher scores mean more symptoms.
Interventions
- DEVICE Active Repetitive Transcranial Magnetic Stimulation 1 Hz
- DEVICE Active Repetitive Transcranial Magnetic Stimulation 10 Hz
- DEVICE Active control site Repetitive Transcranial Magnetic Stimulation at 1Hz
- DEVICE Sham control site Repetitive Transcranial Magnetic Stimulation
- DEVICE Active control site Repetitive Transcranial Magnetic Stimulation at 10 Hz
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT01620086 record still lists
NCT01620086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Active Repetitive Transcranial Magnetic Stimulation 1 Hz is the first listed.
NCT01620086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01620086 about?
NCT01620086 is a clinical study titled "Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia". This study compares the efficacy of low and high frequency repetitive transcranial magnetic stimulation (rTMS) as a means of treating subjects with schizophrenia. Magnetic pulses delivered over the scalp cause brain activity. This activity has been shown to help decrease the intensity and frequency ...
What is the current status of trial NCT01620086?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2012-06. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01620086?
The interventions under investigation include: Active Repetitive Transcranial Magnetic Stimulation 1 Hz (DEVICE), Active Repetitive Transcranial Magnetic Stimulation 10 Hz (DEVICE), Active control site Repetitive Transcranial Magnetic Stimulation at 1Hz (DEVICE), Sham control site Repetitive Transcranial Magnetic Stimulation (DEVICE), Active control site Repetitive Transcranial Magnetic Stimulation at 10 Hz (DEVICE).
Who is sponsoring clinical trial NCT01620086?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01620086's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia